Gen Kanayama, Ph.D., M.D.
This page shows the publications co-authored by Gen Kanayama and Aaron Baggish.
Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23; 135(21):1991-2002.
Kanayama G, DeLuca J, Meehan WP, Hudson JI, Isaacs S, Baggish A, Weiner R, Micheli L, Pope HG. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med. 2015 Nov; 43(11):2638-44.
Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May; 110(5):823-31.
Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul-Aug; 23(4):371-7.
Rothman RD, Weiner RB, Pope H, Kanayama G, Hutter AM, Fifer MA, Dec GW, Baggish AL. Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population. BMJ Case Rep. 2011 Aug 17; 2011.
Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, Pope HG. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010 Jul; 3(4):472-6.
Hudson JI, Kanayama G, Pope HG, Muse S, Kaufman MJ, Baggish A, Waikar SS. Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. Am J Kidney Dis. 2020 07; 76(1):152-155.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.